Atención farmacéutica en pacientes con inmunodeficiencia adquirida y/o tuberculosis en el área ambulatoria de un hospital pediátrico

Kobashigawa, C J; Rousseau, M N.
Med. infant ; 30(4): 346-357, Diciembre 2023. ilus, tab
Artículo en Español | LILACS, UNISALUD, BINACIS | ID: biblio-1524214

Documentos relacionados

  1. [Progress in platelets and tuberculosis].
  2. Sex and Gender Differences in Tuberculosis Pathogenesis and Treatment Outcomes.
  3. Converting cancer therapies into cures: lessons from infectious diseases.
  4. Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.
  5. Rifampicin Can Be Given as Flat-Dosing Instead of Weight-Band Dosing.
  6. When the Quest for a Cure Is Personal.
  7. Childhood Tuberculosis - Time for Shorter and Differentiated Treatment.
  8. Retention of knowledge and clinical competence among Ugandan mid-level health providers 1 year after intensive clinical mentorship in TB and HIV management.
  9. [Multifocal tuberculosis despite immunocompetence].
  10. Improved appropriateness of anti-tuberculosis prescription by the expert prescription review program in Taiwan.